Updated Jul 16, 2026
Nuechterlein Carole has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Carole Nuechterlein is identified in SEC filings as affiliated with Aligos Therapeutics, Inc. as of June 29, 2026. The filing context indicates she is an insider at the company (e.g., potential board member or executive). No additional public biographical details are provided in the given SEC context. Aligos Therapeutics is a biotechnology company; the specific role and responsibilities of Ms. Nuechterlein within the company are not specified in the provided filings.
| Role | Insider |
|---|---|
| Notability | 40/100 |
Carole Nuechterlein is identified in SEC filings as affiliated with Aligos Therapeutics, Inc. as of June 29, 2026. The filing context indicates she is an insider at the company (e.g., potential board member or executive). No additional public biographical details are provided in the given SEC context. Aligos Therapeutics is a biotechnology company; the specific role and respons…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Nuechterlein Carole profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.